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THE PREPARATION AND REACTION OF NOVEL GLYCOSYL
UREAS AND THIOUREAS
Robert Scott Johnson, M.A.
Western Michigan University, 1987

The first phase of this research was to synthesize novel glycosyl
propynyl ureas and glycosyl propynyl thioureas. The second phase involved the
reactions of these compounds.
It was hoped that l-(2,3,4,6-tetra-0-acetyl-fJ-D -glucopyranosyl)-3-(2propynyl) urea would undergo a ring closure when treated with PCI5 to
produce l-(2,3,4,6-tetra-0-acetyl-p-D -glucopyranosyl)-lH -5-m ethyl-2-im idazolone. However, this was not the case. It is believed that the 3N position of
the glycosyl propynyl ureas and glycosyl propynyl thioureas must be
disubstituted for th e reaction to occur and yield a 2-imidazolone product.
A glycosyl propynyl thiourea was reacted with dibenzylazodicarboxylate
to produce Nl-(2,3,4,6-tetra-0-acetyl-p-D-glucopyranosyl)-N2-(2-propynyl)-S(N3,N4-biscarbobenzoxy)hydrazinoisothiourea. Further investigation with this
compound may lead to a novel glycosyl carbodiimide.
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CHAPTER I

INTRODUCTION

The objective o f this research project has been the construction o f a
nucleoside antagonist that contains a five membered heterocyclic moiety
which is novel. The reaction them e was to design a compound which is similar
to the pyrimidine and purine bases that are found in deoxyribonucleic acids
(DNA) and ribonucleic acids (RNA). These molecules are known to transmit
genetic information and m ediate the synthesis of proteins in the cell.

The

chem ical properties and exact structures of the pyrimidine and purine bases
d ictate the interactions possible between the respective DNA strands and
between molecules o f DNA and RNA. These interactions not only store but
also transmit the genetic information in the cell.

Hence, pyrimidine and

purine bases play a key role in the metabolic processes of the cell.
The target compound was l-(2,3,4,6-tetra-0-acetyl-p-D -glucopyranosyl)-lH -5-m ethyl-2-im idazolone.

There are at least two different approaches

on paper to synthesize l-(2,3,4,6-tetra-0-acetyl-p -D -glu cop yran osyl)-3-(2propynyl)urea which is a key precursor to the target compound. Figures 5 and
6 illustrate the two schem es that yield l-(2,3,4,6-tetra-0-acetyl-p -D -glu copyranosyl)-lH-5-m ethyl-2-im idazolone.
The purine ring system contains an imidazole ring fused to a pyrimidine
ring.

It is hoped that l-(2,3,4,6-tetra-0-acetyl-p-D -glucopyranosyl)-lH -5-

methyl-2-imidazolone will mimic the structure of the bases found in DNA and

1
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RNA thereby blocking the synthesis o f the natural base nucleotides. This may
disrupt the metabolic process in cancer cells.
It is w ell known that cancer cells reproduce in an uncontrolled manner
compared with normal cells and are usually more susceptible to drugs. It must
be noted that every drug which is used for the treatm ent of cancer is also
toxic to the entire human body.
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CHAPTER II

HISTORICAL
Throughout the history o f medicinal chemistry the imidazole nucleus has
proven itself to be an active source o f medicinal agents. Nitroimidazoles are
frequently linked with antim icrobial a c tiv ity .

T hese com pounds are

synthesized in order to combat infections by trichomonas, a protozoan.
Protozoal infections are not usually serious y e t they can be annoying.
Therefore, these types of agents are important to medicinal chem ists.
Azomycin (Figure 1) is one such agent that was isolated from a culture broth
N

Figure 1.

N
H

Azomycin

N 02

from a Streptomyces strain.1 Two other antitrichomonal agents (Figure 2) are
dimetridazole, which is used in veterinary practice and metronidazole, a
compound that is used to combat vaginal trichomoniasis.2
N

0 2N

ch 3
N

I
CH3

dimetridazole
Figure 2.

CH3

o 2n

N

I
c h 2ch 2o h

metronidazole

Antitrichomonal Agents
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There are numerous nucleoside derivatives that contain a five member
heterocyclic moiety which exhibit biological activity. One such compound is
l-p-D-ribofuranosyl-l,2,4-triazole-3-carboxam ide3 (Figure 3).

Ribavirin is

very effectiv e against influenza virus in mice.
0
II

hoch2

OH
Figure 3.

OH

Ribavirin, l-p-D-ribofuranosyl-l,2,4-triazole-3-carboxam ide

Nucleoside analogs differ greatly from each other with respect to the
biological systems they can a ffect.

These nucleosides can undergo a great

deal of metabolic conversions and, therefore, they can a ffect a variety of
metabolic targets. It is not possible to predict the potential activity of the
nucleoside.

Structural change in th e h e te r o c y c le as w ell as in th e

carbohydrate moiety has produced biologically active compounds. It must be
pointed out that the correlation between structure and activity cannot be
determined with any kind o f certainty.
Stoffel and Speziale* discovered a novel ring closure of propynylureas
using phosphorus pentachloride to produce 2-imidazolones. The 2-imidazolone
is produced via an imidazolium chloride (Figure 4). A 2-imidazolone was the
target heterocyclic moiety for this project.
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2,3,4,6-tetra-O -acetyla-D-glucopyranosyl bromide
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CH2OAc
N = C=

0

AgOCN, 100°C
OAc

xylene, 2 hours

AcO

OAc
H
2,3,4,6-tetra-O -acetyl-p-D glucopyranosyl isocyanate
CH2OAc
N

H2NCH2C = C - H

- C - N - CH2 - C = C — H

OAc

CHCI3, heat, 1 hour
AcO

OAc
H
l-(2,3,4,6-tetra-0-acetyl-p-D -glucopyranosyl)3-(2-propynyl)urea
(1)
CH2OAc

PCI5, CH2CI2,
heat, 3 hours

n
\ C

5% NaHC03
AcO

H
OAc
l-(2,3,4,6-tetra-0-acetyl-p-D -glucopyranosyl)-lH -5-m ethyl-2-im idazolone
(2)
Figure 5. Approaching the problem on paper
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2,3,4,6-tetra-O-acetyl-p-D-glucopyranosyl azide
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OAc

H

Ni+2 Na3A103+3H2

2,3,4,6-tetra-O-acetyl-p-D-glucopyranosyl amine
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^ H—C = C —CH2—N=C=0
propargyl isocyan ate

propargyl bromide

(4)
(3) + (4)
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*»
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PCI5, CH2CI2,
(1)

5% NaHC0 3
►

heat, 3 hours

Figure 6. Approaching the problem on paper.

Reproduced with permission o f the copyright owner. Further reproduction prohibited without permission.

(2)

CHAPTER III

EXPERIMENTAL
The compounds synthesized during this project were identified by IR
and elem ental analysis. The IR spectra were obtained by using a Beckman
Acculab Spectrophotometer.

Microanalyses were carried out by Midwest

Microlab of Indianapolis, Indiana and MicAnal of Tucson, Arizona. Melting
points were determined with a Thomas Hoover Uni-melt Capillary Melting
Point apparatus, and are uncorrected.
Preparations

2.3.4.6-tetra-O-q-D-glucoDvranosvl bromide
This compound was synthesized by a modification of the procedure of
R. Lemieux.5
0-D-glucose pentacetate, 146 g (.375 mol), was added to 325 mL of
acetic anhydride in a 2 L round bottom flask that has three necks.

A

thermometer was placed in the first neck, a mechanical stirrer in the
middle and a pressure equalizing addition funnel in the last. The mixture
was stirred and cooled to 15°C then 47.5 g (1.53 mol) of anhydrous red
phosphorus was added. Five minutes later 62.5 mL (1.21 mol) of bromine
was added dropwise to keep the reactions mixture between 5-20 °C. Next
62.5 mL of water was added slowly, keeping the temperature in the 5-20°C
range.

The reaction mixture was stirred for 2 hrs.

Then 375 ml of

8
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chloroform was added and the mixture was filtered.The red phosphorus was
discarded and the amber filtrate was poured onto 1000 g of ice in a separatory
funnel. The mixture was shaken and the layers separated. The water layer
was extracted tw ice with 150 mL of chloroform. The combined chloroform
extracts were washed with 400 mL of an ice cold sodium hydrogen carbonate
solution. The chloroform solution was dried with calcium chloride. Next the
chloroform was removed by the flash evaporator.

A thick yellow syrup

remained. This syrup was crystallized by the addition of a 50:50 mixture of
light petroleum ether and diethyl ether. Yield o f the crude product was 115 g
(75% theoretical), m.p. 73-77°C. This compound can be kept in a desiccator
over phosphorus pentoxide and potassium hydroxide under reduced pressure
and used within forty-eight hours. Recrystallization from diethyl ether, m.p.
88-89°C.
2.3.4.6-tetra-Q-acetvl-B-D-glucopyranosvl isocyanate
A modified procedure o f the procedure of B. Johnson and W. Bergmann
was used to prepare this compound.^
In a 1 L round bottom, triple necked flask that was fitted with
mechanical stirrer was placed 66 g (.17 mol) o f 2,3,4,6-tetra-O -acetyl-a-D glucopyranosyl bromide, 230 mL of xylene that was dried over sodium, and
24 g (.17 mol) o f silver cyanate. The mixture was placed on a steam bath for
30 minutes, the silver cyanate turned yellow due to the formation of silver
bromide, then 12 g (.08 mol) more of silver cyanate was added and the mixture
was heated for 30 more minutes. Finally 12 g (.08 mol) of silver cyanate was
added and the mixture was placed on the steam bath for one more hour. The

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

solution was then filtered by suction to remove the silver salts. The filtrate
was poured into 400 mL of light petroleum ether.

The mother liquor was

decanted into 200 mL o f light petroleum ether. This solution was then poured
into a new vessel and was placed in the freezer overnight. The yield was 15 g
(23% theoretical), m.p. 95°C. Infrared spectrum (KBr):v (N=C=0), 2250 cm ~l.

l-(2.3.4.6-tetra-Q-acetvl-B-D-glucopvranosvl)3-(2-proDvnvl)urea
In a 100 mL round bottom flask was placed 4.20 g (.011 mol) o f 2,3,4,6tetra-O-acetyl-0-D-glucopyranosyl isocyanate in 50 mL of chloroform. Then
.680 g (.012 mol) of propargyl amine in 10 mL of chloroform was added and
the mixture was refluxed for 1 hr. The chloroform was removed with the aid
of the flash evaporator and a yellow syrup remained.
crystallized by adding diethyl ether.

This syrup was

The crude product was purified by

recrystallization from water. Yield 3.7 g (77% theoretical), m.p. 142-143°C.
IR (KBr) cm -ls

3200-3500 (N-H stretch), 2320 (C =C -), 1750 (C=0 acetate),

1650 (C=0 amide), 1560 (N-H bend). Elemental analysis: found C 49.99, H
5.52, N 6.50} calculated C 50.47, H 5.64, N 6.54.

2.3.4.6-tetra-Q-acetvl-a-D-glucopvranosvl chloride
This compound was made using a modification of the procedure of
R. Lemieux.7
Forty grams of p-D-glucose pentaacetate (.102 mol) was dissolved in
200 mL of chloroform which was contained in a 500 mL round bottom flask
equipped with a condenser that was fitted with a calcium chloride tube.
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A

solution of 11.6 mL (20.0 g) o f titanium tetrachloride in 80 mL o f chloroform
was added.

The mixture was shaken and the yellow precipitate dissolved.

This solution was refluxed 3 hrs on a steam bath and then was added to a 400
mL ice water mixture that was in a 2 L separatory funnel. The chloroform
layer was washed twice with 200 mL o f water, dried with calcium chloride and
evaporated to a syrup using the flash evaporator. The syrup was added to 100
mL o f anhydrous ether. Light petroleum ether was then added to the mixture
to make the solution turbid.

Crystallization soon took place.

product was washed with 40 mL of cold diethyl ether.

The crude

The yield was 32 g

(8596 theoretical), m.p. 72-74°C. A fter recrystallizat3on from diethyl ether
the substance melted at 75-76°C.
2.3.4.6-tetra-O-acetvl-B-D-glucopvranosvl azide
This compound was synthesized by a modification o f the procedure of
A. Yamamoto, C. Miyashita, and H. Tsukamoto.8
In a 250 mL round bottom flask was placed 3.2 g (.05 mol) of sodium
azide in 100 mL o f DMF. Then 16.1 g (.044 njol) o f 2,3,4,6-tetra-O -acetyl-aD-glucopyranosyl chloride was added.

The mixture was heated on a steam

bath for 30 minutes and 80 mL of acetone was added through the top o f the
condenser. The mixture was refluxed for 2 hrs and then filtered to remove
the sodium chloride. Vaporization of the solvent using th e flash evaporator
left a brown oil.

A 50:50 mixture o f diethyl and light petroleum ether was

added to induce crystallization.

Yield 13.3 g (8196 theoretical), m.p. 123-

124°C.
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2.3.4.6-tetra-0-acetvl-8-D -glucopvranosvl isothiocvanate
This compound was synthesized by a modification of the procedure of
B. Johnson and W. Bergmann.9
In a 1 L flask equipped with a condenser and a mechanical stirrer was
placed 61.6 g (.150 mol) of 2,3,4,6-tetra-O-acetyl-p-D-glucopyranosyl bromide
that w as dissolved in 375 mL of water-free toluene. This mixture was stirred
while 49.8 g (.301 mol) o f AgSCN was added.

The reaction mixture was

refluxed for 1 hr. Yellow silver bromide precipitated as the reaction went to
completion.

The silver bromide was filtered and the filtrate was concen

trated. This solution was put in the refrigerator overnight. The product was
obtained in almost quantitative yield.

This yellow compound had a m.p. of

100-103°C.

l-(2.3.4.6-tetra-0-acetvl-B-D-glucopvranosvl)3-(2-proDvnvllthiourea
In 25 mL of CH2CI2 7.20 g (.018 mol) o f 2,3,4,6-tetra-O -acetyl-p-D glucopyranosyl isothiocyanate was dissolved.

Then one gram (.018 mol) of

propargyl amine in 10 mL o f CH2CI2 was added to the reaction vessel. The
mixture was refluxed for 1 hr and then the solvent was removed.

The

resulting syrup was dissolved in absolute ethanol and eluted through a column
of silica gel.

The ethanol was removed.

Every attempt to crystallize the

syrup failed. Yield 6.5 g (79% theoretical). IR (neat) cm_l: 3200-3400 (N-H
stretch), 2320 (C =C -), 1750 (C=0 acetate), 1545 (N-H bend), 1340 (C=S).
Elemental analysis: found C 48.55, H 5.84, N 6.02, S 6.39; calculated C 48.65,
H 5.43, N 6.30, S 7.20.
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l-(2.3.4.6-tetra-0-acetvl-B-D-glucoDvranosvl)lH-5-methvl-2-imidazolone
In a 100 mL round bottom flask was placed 3.700 g (.0086 mol) of
l-(2,3,4,6-tetra-0-acetyl-p-D-glucopyranosyl)-3-(2-propynyl)urea in 45 mL of
methylene chloride.

Then 1.750 g (.0086 mol) of PCI5 was added and the

mixture was refluxed for 3 hrs. After 1 hr the mixture turned black. A 5%
sodium bicarbonate solution was added to the reaction mixture. The organic
layer was washed and then separated from the aqueous layer.

CaCl2 was

added to the solvent layer and was removed by filtration after 15 minutes.
The methylene chloride was removed. This black residue had an identical IR
spectra as the starting material. 10 An elem ental analysis was not taken on
this substance.

l-(2.3.4.6-tetra-Q-acetvl-B-D-glucopvranosvl)3-methvl-3-(2-Dropvnvl)-thiourea
In a 250 mL round bottomed flask was placed 20.00 g (.0154 mol) of
2,3,4,6-tetra-O -acetyl-p-D -glu cop yran osyl isoth iocyan ate in 75 mL of
CH2CI2. Next 3.500 g (.0154 mol) of N-methyl propargyl amine was added to
the reaction flask. The contents were refluxed for 1 hr and the solvent was
removed. This syrup was crystallized by adding a 50:50 mixture of 30/60 pet.
ether and diethyl ether. It took eight days for the syrup to crystallize. Yield
19.6 g (83% theoretical).

Melting point 105-107°C.

IR (KBr) cm-1: 2320

( O C —), 1750 (C=0), 1430 (C=S). Elemental analysis: found C 49.37, H 5.85,
N 6.02, S 6.71; calculated C 49.78, H 5.70, N 6.13, S 6.98.
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l-(2.3.4.6-tetra-Q-acetvl-B-D-glucopyranosvl)3.5-dimethvl-2-imidazolone
In a 100 mL round bottom flask was placed 2.000 g (.0043 mol) of
l-(2,3,4,6-tetra-O-acetyl-0-D-glucopyranosyl)-3-methyl-3-(2-propynyl)-thiourea
in 30 mL of CH2CI2.

Next .8900 g (.0043 mol) of PCI5 was added and the

solution was refluxed for 3 hrs. The reaction mixture was washed with a 5%
sodium bicarbonate solution. The organic layer was separated from the water
layer and was dried with CaCl2. The drying agent was removed by filtration
and then the solvent was taken away leaving a yellow syrup that could not be
crystallized. TLC indicated one compound but the elem ental analysis did not
agree with the calculated value for the target compound.H

Elem ental

analysis: found C 44.05, H 4.83, N 4.74; calculated C 51.58, H 5.88, N 6.33.

N l-(2.3.4.6-tetra-Q-acetvl-B-D-glucopvranosvl)-N2(2-propvnvl)-S-( N3.N 4-bi8carbobenzoxv)hvdraz inoisothiour ea
A modified procedure of De, Shiau, and Harmon was used to prepare this
compound. 12
Four grams (.009 mol) of l-(2,3,4,6-tetra-0-acetyl-p-D -glucopyranosyl)3-(2-propynyl)thiourea was dissolved in 35 mL of CH2CI2. This mixture was
cooled to 10°C and 2.68 g (.009 mol) of dibenzylazodicarboxylate was added
dropwise to the reaction mixture while it was being stirred. The reaction was
allowed to mix for 24 hrs. at room temperature. The methylene chloride was
removed.

The syrup did not crystallize.

Yield 5.1 g (74% theoretical).

Elemental analysis: found C 53.75, H 4.43, N 6.60, S 4.41; calculated C 53.54,
H 4.98, N 7.30, S 4.19.
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CHAPTER IV
RESULTS AND DISCUSSION

The target compound l-(2,3,4,6-tetra-0-acetyl-p-D -glucopyranosyl)-lH 5-methyl-2-imidazolone was not obtained in this project.

The chem ical

rational used to design this compound can be summarized by the following
reaction mechanisms:
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I believe that position three of the urea or thiourea must be disubsti
tuted as in the compound l-(2,3,4,6-tetra-0-acetyl-p-D -glucopyranosyl)-3methyl-3-(2-propynyl)thiourea for a ring closure to occur with PCI5.

In the

case where position N-3 was monosubstituted with a 2-propargyl group the
black residue was actually the starting material l-(2 ,3 ,4 ,6 -tetra -0 -a cety l-p D-glucopyranosyl)-3-(2-propynyl)-urea.

The IR spectra of both substances

were identical. However, when the N-3 position was disubstituted as was the
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case when l-(2,3,4,6-tetra-0-acetyl-p-D-glucopyranosyl)-3-m ethyl-3-(2-propynyl)thiourea was used as the starting material the IR spectra of reactant and
product were not the same. The elem ental analysis was not in an acceptable
range for the expected product. TLC only indicated one compound present
and the NMR was not available to use so the structure was undetermined at
this tim e.
Scheme 1 of Figure 5 was the actual model used in this project because
l-(2,3,4,6-tetra-0-acetyl-p-D-glucopyranosyl)-3-(2-propynyl)urea was synthe
sized before 2,3,4,6-tetra-O-acetyl-p-D-glucopyranosyl amine.
Scheme 2 o f figure 5 was abandoned.

Therefore,

If more tim e were available it is

believed that l-(2,3,4,6-tetra-0-acetyl-p-D -glucopyranosyl)-3-m ethyl-3-(2propynyl)thiourea could undergo a ring closure to produce a 2-imidazolone.
This project was not a failure because four novel compounds were synthesized.
They are l-(2,3,4,6-tetra-0-acetyl-p-D -glucopyranosyl)-3-(2-propynyl)urea,
l-(2,3,4,6-tetra-0-acetyl-p-D-glucopyranosyl)-3-(2-propynyl)thiourea, l-(2 ,3 ,4 ,6 tetra-0-acetyl-p-D-glucopyranosyl)-3-methyl-3-(2-propynyl)thiourea, and N1(2,3,4,6-tetra-0-acetyl-p-D -glucopyranosyl)-N 2-(2-propynyl)-S-(N 3,N 4-biscarbobenzoxy)hydrazinoisothiourea. All of these compounds are hgdroscopic.
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